GSK3B and schizophrenia: Our earlier research revealed for the first time a novel connection between specific gene polymorphisms related to neuroplasticity and protein kinases (including MAPK, BDNF, GSK3β, and AKT1) and the development of schizophrenia symptoms that predict a poor disease outcome [45].